Australia's Aroa Biosurgery eyes worst day ever on lowering FY25 forecasts

Aroa Biosurgery

29/01/2025 01:20

** Shares of Aroa Biosurgery  ARX.AX  fall 18.1% to A$0.655,
on track for their biggest-ever intraday drop
    ** Wound healing products maker fell as much as 19.1%
earlier in the day, hitting lowest level since Dec. 18
    ** Co cuts FY25 normalised EBITDA profit guidance to a range
between NZ$2 mln ($1.13 mln) and NZ$4 mln, from earlier guidance
of NZ$2 mln to NZ$6 mln 
    ** Cuts FY25 total revenue guidance to between NZ$81 mln and
NZ$84 mln from earlier guidance of NZ$80 mln to NZ$87 mln
    ** About 901,488 shares change hand, compared to 30-day
average trading volume of 318,195 shares 
    ** Stock down around 15% this year, including the day's
moves   


($1 = 1.7680 New Zealand dollars)

 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))